Specimen self-collection and HPV DNA screening in a pilot study of 100,242 women

International Journal of Cancer

Volumn 135, Issue 1, 2014, Pages 109-116

  Lazcano Ponce, Eduardo ^a   Lorincz, Attila T ^b   Torres, Leticia ^a   Salmerón, Jorge ^a,c   Cruz, Aurelio ^a   Rojas, Rosalba ^a   Hernández, Pilar ^a   Hernández, Mauricio ^a  

^a INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

cervical cancer; high risk HPV testing; Mexico; vaginal self collected samples

Indexed keywords

CERVICAL CANCER; HIGH-RISK HPV TESTING; MEXICO; VAGINAL SELF-COLLECTED SAMPLES;

ADULT; AGED; EARLY DETECTION OF CANCER; FEMALE; HUMAN PAPILLOMAVIRUS DNA TESTS; HUMANS; MEXICO; MIDDLE AGED; NEOPLASM GRADING; SPECIMEN HANDLING; UTERINE CERVICAL NEOPLASMS;

EID: 84899463359     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28639     Document Type: Article

References (37)

1. Szarewski A,. Ushering in a new era: human papillomavirus (HPV) testing comes to the NHS cervical screening programme. J Fam Plann Reprod Health Care 2011; 37: 64-7.
2. Ronco G, Giorgi-Rossi P, Carozzi F, et al. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. Lancet Oncol 2010; 11: 249-57.
3. Bulkmans NW, Berkhof J, Rozendaal L, et al. Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial. Lancet 2007; 370: 1764-72.
4. Mayrand MH, Duarte-Franco E, Rodrigues I, et al. Canadian Cervical Cancer Screening Trial Study Group. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N Engl J Med 2007; 357: 1579-88.
5. Naucler P, Ryd W, Törnberg S, et al. Human papillomavirus and Papanicolaou tests to screen for cervical cancer. N Engl J Med. 2007; 357: 1589-97.
6. Sankaranarayanan R, Nene BM, Shastri SS, et al. HPV screening for cervical cancer in rural India. N Engl J Med 2009; 360: 1385-94.
7. Kitchener HC, Almonte M, Thomson C, et al. HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial. Lancet Oncol 2009; 10: 672-82.
8. Anttila A, Kotaniemi-Talonen L, Leinonen M, et al. Rate of cervical cancer, severe intraepithelial neoplasia, and adenocarcinoma in situ in primary HPV DNA screening with cytology triage: randomised study within organised screening programme. BMJ 2010; 340: c1804.
9. Hernández-Avila M, Lazcano-Ponce E, Martínez O,. Public policies for HPV screening and vaccination in Mexico. In the 27th International Papillomavirus Conference and Clinical Workshop. Berlin, Germany, September 17-23, 2011.
10. Secretaría de Salud. Programa de acción específico 2007-2012 Cáncer Cervicouterino, 1st edn. México, D.F.: Secretaría de Salud, 2008.
11. Lazcano-Ponce E, Lörincz AT, Salmerón J, et al. A pilot study of HPV DNA and cytology testing in 50,159 women in the routine Mexican social security program. Cancer Causes Control 2010; 21: 1693-700.
12. Salmerón J, Lazcano-Ponce E, Lorincz A, et al. Comparison of HPV-based assays with Papanicolaou smears for cervical cancer screening in Morelos State, Mexico. Cancer Causes Control 2003; 14: 505-12.
13. Lazcano-Ponce E, Lorincz AT, Cruz-Valdez A, et al. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial. Lancet 2011; 378: 1868-73.
14. Sowjanya AP, Paul P, Vedantham H, et al. Community Access to Cervical Health Study Group. Suitability of self-collected vaginal samples for cervical cancer screening in periurban villages in Andhra Pradesh, India. Cancer Epidemiol Biomarkers Prev 2009; 18: 1373-8.
15. Gravitt PE, Belinson JL, Salmeron J, et al. Looking ahead: a case for human papillomavirus testing of self-sampled vaginal specimens as a cervical cancer screening strategy. Int J Cancer 2011; 129: 517-27.
16. Petignat P, Vassilakos P,. Is It Time to Introduce HPV Self-Sampling for primary cervical cancer screening? JNCI 2012; 194: 166-7.
17. Waller J, McCaffery K, Forrest S, et al. Acceptability of unsupervised HPV self-sampling using written instructions. J Med Screen 2006; 13: 208-13.
18. Mitchell S, Ogilvie G, Steinberg M, et al. Assessing women's willingness to collect their own cervical samples for HPV testing as part of the ASPIRE cervical cancer screening project in Uganda. Int J Gynaecol Obstet 2011; 114: 111-5.
19. Sellors JW, Lorincz AT, Mahony JB, et al. Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions. CMAJ 2000; 163: 513-8.
20. Stewart DE, Gagliardi A, Johnston M, et al. Self-collected samples for testing of oncogenic human papillomavirus: a systematic review. J Obstet Gynaecol Can. 2007; 29: 817-28.
21. Dzuba IG, Díaz EY, Allen B, et al. The acceptability of self-collected samples for HPV testing vs. the pap test as alternatives in cervical cancer screening. Womens Health Gend Based Med 2002; 11: 265-75.
22. National Institute of Statistics and Geography. Data bank. Interactive data consulting. Mexico Population and Housing Census 2010. Female population aged over 12 by age and Seguro Popular affiliation. National Institute of Statistics and Geography, 2010. Available at: http://www.inegi.org.mx/lib/olap/ consulta/general-ver4/MDXQueryDatos.asp? #Regreso&c=27874; in Spanish. Last accessed on May 31 2012, Mexico City.
23. Gómez Dantés O, Sesma S, Becerril VM, et al. The health system of Mexico. Salud Publica Mex. 2011; 53: s220-s32.
24. Knaul FM, González-Pier E, Gómez-Dantés O, et al. The quest for universal health coverage: achieving social protection for all in Mexico. Lancet 2012; 380: 1259-79.
25. Kupets R, Paszat L,. Physician and patient factors associated with follow up of high grade dysplasias of the cervix: a population-based study. Gynecol Oncol 2011; 120: 63-7.
26. Lorincz, AT,. Hybrid CaptureTM method for detection of human papillomavirus DNA in clinical specimens: a tool for clinical management of equivocal Pap smears and for population screening. J Obstet Gynaecol Res 1996; 22: 629-636.
27. Reid R,. Colposcopy of cervical preinvasive neoplasia. In:, Singer A, ed. Premalignant lesions of the lower genital tract, vol. 2. New York: Elsevier, 1990. 87-116.
28. United Mexican States-Ministry of Health. Amendment to Mexican Official Standard NOM-014-SSA2-1994, for the prevention, treatment and management of cervical cancer and breast cancer in primary care, to read as NOM-014-SSA2- 1994, for the prevention, detection diagnosis, treatment, control and surveillance of cervical cancer. United Mexican States-Ministry of Health, 1995. Available at: http://www.salud.gob.mx/unidades/cdi/nom/m014ssa24.html; in Spanish. Last accessed on Oct 7, 2011, Mexico City.
29. Cronin AM, Vickers AJ,. Statistical methods to correct for verification bias in diagnostic studies are inadequate when there are few false negatives: a simulation study. BMC Medical Research Methodol 2008; 8: 75.
30. Begg CB, Greenes RA,. Assessment of diagnostic tests when disease verification is subject to selection bias. Biometrics 1983; 39: 207-215.
31. Belinson JL, Du H, Yang B, et al. Improved sensitivity of vaginal self-collection and high-risk human papillomavirus testing. Int J Cancer 2012; 130: 1855-60.
32. Flores Y, Bishai D, Lazcano E, et al. Improving cervical cancer screening in Mexico: results from the Morelos HPV Study. Salud Publica Mex 2003; 45: S388-S98.
33. Stoler MH, Vichnin MD, Ferenczy A, et al. The accuracy of colposcopic biopsy: Analyses from the placebo arm of the Gardasil clinical trials. Int J Cancer 2011; 128: 1354-62.
34. Pretorius RG, Peterson P, Azizi F, et al. Subsequent risk and presentation of cervical intraepithelial neoplasia (CIN) 3 or cancer after a colposcopic diagnosis of CIN 1 or less. Am J Obstet Gynecol 2006; 195: 1260-5.
35. Arbyn M, Simoens C, Van Oyen H, et al. Analysis of 13 million individual patient records pertaining to Pap smears, colposcopies, biopsies and surgery on the uterine cervix (Belgium, 1996-2000). Prev Med 2009; 48: 438-43.
36. Khan MJ, Castle PE, Lorincz AT, et al. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst 2005; 97: 1072-9.
37. Galgano MT, Castle PE, Atkins KA, et al. Using biomarkers as objective standards in the diagnosis of cervical biopsies. Am J SurgPathol 2010; 34: 1077-87.